Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion type Assertion NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_head.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion wasGeneratedBy ECO_0000203 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion wasDerivedFrom befree-20150227 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion SIO_000772 21703428 NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion evidence source_evidence_literature NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.
- NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_assertion description "[Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pal-7 provided significant 75% inhibition of lung tumor growth in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808878.RAy_s6sAOWRKMy4QHEU_mH0cjxTzYr-9wWd84YfCJGRSE130_provenance.